Psilocybin found safe for consumption in largest ever controlled study (independent.co.uk)

Article summary

A recent study found psilocybin, the psychoactive compound in magic mushrooms, to be safe for human consumption in a controlled setting. The study, conducted at King's College London, involved 89 healthy volunteers who received varying doses of psilocybin or a placebo. The results showed no serious adverse effects, with most minor adverse events being related to expected psychedelic effects. The study's findings support further development of psilocybin as a potential treatment for mental health disorders, including depression.

Main themes

• psilocybin safety
• psychedelic therapy
• depression treatment
• medical marijuana
• regulation and standardization

What commenters say

• Psilocybin has the potential to be a groundbreaking treatment for mental health disorders, including depression, and its safety has been demonstrated in a controlled study.
• The therapeutic benefits of psilocybin are not just about the substance itself, but also about the context and setting in which it is used.
• Some people are skeptical about the medical benefits of psilocybin and cannabis, and believe that more research is needed to fully understand their effects.
• The regulation and standardization of psychedelic substances and herbal supplements are crucial to ensuring their safety and efficacy.
• The comparison between pharmaceuticals and herbal supplements is not always straightforward, and different people may have different preferences and priorities when it comes to their healthcare.
• The potential benefits of psilocybin and cannabis for mental health treatment are significant, and further research is needed to fully explore their therapeutic potential.
• There are concerns about the quality control and testing of cannabis products, and some people question the accuracy of labels and testing results.